Tg(Ighm-Ctla4Ig/Cd80)1Jbs
Transgene Detail
|
Symbol: |
Tg(Ighm-Ctla4Ig/Cd80)1Jbs |
Name: |
transgene insertion 1, Jeffery Bluestone |
MGI ID: |
MGI:3711772 |
Synonyms: |
ScalphaCtla-4, Tg(Ighm-Igh/Igk/Cd80)1Jbs, Tg ScalphaCtla-4, u.7M-4F10scFv-B7.1 |
Transgene: |
Tg(Ighm-Ctla4Ig/Cd80)1Jbs Location: unknown
|
Alliance: |
Tg(Ighm-Ctla4Ig/Cd80)1Jbs page
|
|
|
Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Mutation details: The transgene contains a mouse anti-Ctla4Ig/Cd80 fusion cDNA from which a cell surface bound form of the CD152 antigen (Ctla4Ig) is expressed under control of the IgM heavy chain promoter and enhancer, which directs expression to B cells. To prevent reverse signaling in the transgene expressing cell, the construct was created using a DNA fragment expressing the transmembrane domain from Cd80(B7-1), which lacks the C-terminal, intra-cytoplasmic tail.
(J:113109)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:113109 Fife BT, et al., Inhibition of T cell activation and autoimmune diabetes using a B cell surface-linked CTLA-4 agonist. J Clin Invest. 2006 Aug;116(8):2252-61 |
All: |
1 reference(s) |
|